CLIA Creatine Kinase Isoenzyme Whole Blood Reagent
  • CLIA Creatine Kinase Isoenzyme Whole Blood Reagent Manufacturers, CLIA Creatine Kinase Isoenzyme Whole Blood Reagent Factory, Supply CLIA Creatine Kinase Isoenzyme Whole Blood Reagent
  • CLIA Creatine Kinase Isoenzyme Whole Blood Reagent Manufacturers, CLIA Creatine Kinase Isoenzyme Whole Blood Reagent Factory, Supply CLIA Creatine Kinase Isoenzyme Whole Blood Reagent

CLIA Creatine Kinase Isoenzyme Whole Blood Reagent

Brand :Norman

Product origin :Nanjing

Delivery time :Two weeks after payment

Supply capacity :100,000 units/month

Chemiluminesence Immonoassay Ck MB (Creatine Kinase Isoenzyme) test kits
1. Important indicator for diagnosis of AMI.
2. Analyze re-infarction and infarction size.

Chemiluminesence Immonoassay Ck MB (Creatine Kinase Isoenzyme) Test Reagent:


Methodology: Chemiluminescence immunoassay


Product show:

564454.jpg                                                                                                 

CK-MB:                                                                                                           

1. Registration No: Jiangsu food and drug administration 2014-2400618.
2. Important indicator for diagnosis of AMI.
3. Analyze  re-infarction and infarction size.


Clinical Significance:                                                                                       
1. Began to rise after 3-8 hrs
2. Reach peak value after 8-24hrs  
3. Return to normal value after 3 days
4. Early diagnosis of AMI and risk stratification .
5. Most valuable markers of non-ST-segment elevation MI
6. CK-MB  mainly exists inmyocardium. Content of CK-MB in serum is sensitive and specific to myocardial damage.
7.CK-BB Mainly exists in brain, prostate,intestine,lung,bladder,uterus,placenta,and goiter.
CK-MM  Mainly exists in skeletal muscle and myocardium.

Product advantage:                                                                                         
1. High sensitivity: 0.4ng/ml.
2. High accuracy : 99% result correlation with similar product of Siemens ADVIA Centaur.
3. Wide linear range: 0.4-300ng/ml.

                                                                               

Intended Use

Creatine Kinase-MB (CK-MB) kit (Fluorescein Enhanced Chemiluminescence Immunoassay) is intended for in vitro quantitative determination of Creatine kinase-MB content in human serum and plasma, based on NRM411 system.

CK-MB is mainly from myocardial tissue. The increased level of CK-MB in serum is a significant indicator of diagnosis of acute myocardial infarction (AMI) and identification of myocardial necrosis. In cases of acute myocardial infarction (AMI), the concentration of CK-MB rises as early as 3 to 6 hours after onset, peaks at between 12 and 24 hours, and returns to normal after 3 days if without any complications. However, if there are complications, the level of the enzyme in the serum will remain high. If MI happens again, the decreased level of CK-MB will rise again, and the curve of the enzyme activity will form saddle pattern.


Principle of the Procedure

The assay is a sandwich immunoassay for quantitative determination of CK-MB concentration based on chemiluminescence immunoassay technology. The Magnetic Microbeads Reagent contains protecting reagents and magnetic beads that are coated with FITC antibody. The Antibody Reagent 1 contains the protecting reagent and acridinium ester labeled specific CK-MB antibody. The Antibody Reagent 2 contains the protecting reagent and FITC labeled CK-MB antibody. Sample, calibrator or control is mixed with Magnetic microbeads Reagent and Antibody Reagent to form a sandwich complex. After incubation and automatic magnetic separation conducted by the instrument, trigger solutions are added to generate chemiluminescent reaction and the RLUs are measured by the photomultiplier. A direct relationship exists between the amount of CK-MB in the sample and the RLUs detected by the NRM411 system.



Company profile:                                                                                             

Nanjing Norman Biological Technology Co., Ltd is dedicated to R&D and manufacturing of automated chemiluminescence system. Founded in 2008, Norman biological has been upholding the idea that R&D shapes future ,and concentration determines success. Ever since the beginning,Norman has been focusing on developing and manufacturing  chemiluminescence and immunofluorescence  reagents.


6415.jpg


Agent Wanted: If you are interested in working with us, please feel free to contact. 

61.jpg

Why Us:                                                                                                                

1. Manufacturer and Exporter for nearly 10 years with self R&D Research Center;

2. Professional After-Sale service with On-site support worldwide; 
3. CE/ISO13485/SGS/RoHS Certifications!


OEM and ODM are available !


Get the latest price? We'll respond as soon as possible(within 12 hours)
close left right